Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology
Published in: European Archives of Oto-Rhino-Laryngology 6/2016

01-06-2016 | Miscellaneous

Diagnostic and prognostic value of procalcitonin levels in patients with Bell’s palsy

Authors: Saffet Kilicaslan, Sinan Uluyol, Mehmet Hafit Gur, Ilker Burak Arslan, Ozlem Yagiz

Published in: European Archives of Oto-Rhino-Laryngology | Issue 6/2016

Login to get access

Abstract

Inflammation is thought to play an important role in the pathogenesis of Bell’s palsy (BP). Procalcitonin (PCT) is currently among the most frequently used proinflammatory biomarkers in clinical practice. In this study, we assessed the serum PCT levels for predicting the severity and prognosis of BP. In total, 32 patients with House–Brackmann (HB) grade II and III BP (low-grade group), 22 patients with HB grade IV and V (high-grade group) and 35 healthy individuals (control group) were included in this prospective study. PCT levels were compared among these three groups at the time of diagnosis. All patients received standard prednisolone and acyclovir treatment. The correlation between PCT levels and recovery was analyzed 3 months after treatment. The PCT levels for control, low-grade and high-grade BP groups were 0.01 ± 0.001, 0.35 ± 0.05, and 0.98 ± 0.41 ng/mL, respectively. The PCT level in low-grade group was significantly higher than that in control group (p < 0.001), and the PCT level in high-grade BP group was significantly higher than that in low-grade group (p = 0.01, p < 0.05). The complete recovery rate was 93.7 % in low-grade and 54.5 % in high-grade BP group (p = 0.015, p < 0.05). There was a strong negative correlation between PCT levels and recovery rates (r = −0.896, p < 0.001). PCT levels were significantly associated with the severity of BP and higher PCT levels were related with poor clinical outcome in terms of recovery. These results support the diagnostic and prognostic significance of PCT in patients with early BP.
Literature
1.
Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R et al (2013) Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg 149(3 Suppl):S1–S27CrossRefPubMed
2.
Peitersen E (2002) Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 549:4–30CrossRefPubMed
3.
4.
House JW, Backmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146–147PubMed
5.
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341(8844):515–518CrossRefPubMed
6.
Whicher J, Bienvenu J, Monneret G (2001) Procalcitonin as an acute phase marker. Ann Clin Biochem 38(Pt 5):483–493CrossRefPubMed
7.
Reinhart K, Karzai W, Meisner M (2000) Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 26:1193–1200CrossRefPubMed
8.
Lee WS, Kang DW, Back JH, Kim HL, Chung JH, Shin BC (2015) Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients. Korean J Intern Med 30:198–204CrossRefPubMedPubMedCentral
9.
van Leeuwen HJ, Voorbij HA (2002) Procalcitonin concentrations in the diagnosis of acute inflammatory reactions. Ned Tijdschr Geneeskd 146:55–59PubMed
10.
Mitaka C (2005) Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta 351:17–29CrossRefPubMed
11.
Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC (2010) The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect 60:409–416CrossRefPubMed
12.
Adib-Conquy M, Monchi M, Goulenok C, Laurent I, Thuong M, Cavaillon JM, Adrie C (2007) Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection. Shock 28:406–410CrossRefPubMed
13.
Jonsson L, Larsson A, Thomander L (1987) Immune complexes and complement components in Bell’s palsy. ORL J Otorhinolaryngol Relat Spec 49:294–301CrossRefPubMed
14.
Larsson C, Bernström-Lundberg C, Edström S, Bergström T (1998) Tumor necrosis factor-alpha response and herpesvirus infection in Bell’s palsy. Laryngoscope 108(8 Pt 1):1171–1176CrossRefPubMed
15.
Yilmaz M, Tarakcioglu M, Bayazit N, Bayazit YA, Namiduru M, Kanlikama M (2002) Serum cytokine levels in Bell’s palsy. J Neurol Sci 197:69–72CrossRefPubMed
16.
Bucak A, Ulu S, Oruc S, Yucedag F, Tekin MS, Karakaya F, Aycicek A (2014) Neutrophil-to-lymphocyte ratio as a novel-potential marker for predicting prognosis of Bell palsy. Laryngoscope 124:1678–1681CrossRefPubMed
17.
Kum RO, Yurtsever Kum N, Ozcan M, Yilmaz YF, Gungor V, Unal A, Ciliz DS (2015) Elevated neutrophil-to-lymphocyte ratio in Bell’s palsy and its correlation with facial nerve enhancement on MRI. Otolaryngol Head Neck Surg 152:130–135CrossRefPubMed
18.
Atan D, Ikinciogullari A, Koseoglu S, Ozcan KM, Cetin MA, Ensari S, Dere H (2015) New predictive parameters of Bell’s palsy: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Balkan Med J 32:167–170CrossRefPubMedPubMedCentral
19.
Sullivan FM, Swan IR, Donnan PT et al (2009) A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell’s palsy: the BELLS study. Health Technol Assess 13:iii–iv, ix–xi 1–130
20.
21.
Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B et al (2007) Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med 357:1598–1607CrossRefPubMed
Metadata
Title
Diagnostic and prognostic value of procalcitonin levels in patients with Bell’s palsy
Authors
Saffet Kilicaslan
Sinan Uluyol
Mehmet Hafit Gur
Ilker Burak Arslan
Ozlem Yagiz
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 6/2016
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-3937-1

Other articles of this Issue 6/2016

European Archives of Oto-Rhino-Laryngology 6/2016 Go to the issue

Rhinology

A novel biodegradable frontal sinus stent (MgNd2): a long-term animal study

Otology

Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion

Head and Neck

Thyroglossal duct cyst excision with hyoid bone preservation

Head and Neck

Less may be more: nodal treatment in neck positive head neck cancer patients

Rhinology

Non-allergic rhinitis with eosinophilia syndrome is not associated with local production of specific IgE in nasal mucosa

Review Article

Cancer of the gingiva